Avodart
Avodart

0.92
Avodart is indicated for the long-term treatment of benign prostatic hyperplasia to improve urinary symptoms.


Ingredient
Category
Availability
In Stock
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Product Sheet

Active Ingredient(s)
Dutasteride
Reference Brand
Avodart
Product Origin
Generic Alternative
Reference Manufacturer
GSK
Product Form
Capsule
Regulatory Classification
Rx
Primary Category
Men's Health
Product Category
5-alpha-reductase inhibitor
Pharmacological Class
Androgen inhibitor
Clinical Indications
Benign prostatic hyperplasia
Manufacturer Description
Avodart is indicated for the long-term treatment of benign prostatic hyperplasia to improve urinary symptoms.
Mechanism of Action
Avodart inhibits the 5-alpha-reductase enzymes that convert testosterone to dihydrotestosterone, significantly reducing DHT levels to shrink the prostate gland.
Route of Administration
Oral
Onset Time
Weeks to months
Duration
Continuous
Contraindications
Women, Children
Severe Adverse Events
Mood changes, Allergic reactions
Common Side Effects
Decreased libido, Impotence
Uncommon Side Effects
Breast tenderness, Skin rash
Pregnancy Safety Warnings
Not for use by women.
Age Restrictions
Adult men.
Storage Guidelines
Store below 30°C in a dry place.
Related Products
Proscar, Finasteride

Avodart FAQ

Can Avodart be used for hair loss in men?

Clinical studies have shown that dutasteride can reduce scalp DHT more effectively than finasteride, leading to measurable hair regrowth in men with androgenetic alopecia. This use is off-label and should only be considered after a thorough discussion with a dermatologist or qualified physician.

How long does it take to see improvement in urinary symptoms?

Most men notice a reduction in urinary frequency and nighttime trips after 4-6 weeks of daily dosing, although maximal benefits may require several months of continuous therapy.

Does Avodart affect PSA test results for prostate cancer screening?

Yes. Dutasteride lowers PSA levels by roughly 50 % after three months of treatment. Healthcare providers adjust PSA interpretation by doubling the measured value or using a correction factor when monitoring patients on Avodart.

Is it safe to handle crushed Avodart tablets during pharmacy work?

Pregnant or nursing women should avoid direct contact with crushed dutasteride tablets because of the risk of fetal exposure. Pharmacy staff should use gloves and follow standard safety procedures.

What should I do if I miss a dose on a weekend?

Take the missed pill as soon as you remember on the same day. If you realize the omission the next day, skip the missed dose and resume your regular once-daily schedule; do not double the dose.

Are there any dietary restrictions while taking Avodart?

No specific foods or beverages interfere with dutasteride absorption. Maintaining a balanced diet and staying hydrated supports overall prostate health.

Can Avodart be combined with other BPH medications?

Yes. Dutasteride is often prescribed together with an alpha-blocker (e.g., tamsulosin) to provide both rapid symptom relief and long-term prostate volume reduction. Combination therapy should be managed by a physician.

Is routine blood monitoring required for all patients?

Baseline liver function testing is recommended, especially in men with known hepatic disease. Ongoing monitoring is usually performed only if liver abnormalities develop or if the patient experiences concerning symptoms.

How should Avodart be stored during travel?

Keep the medication in its original container, protected from heat and moisture. A small insulated pouch can help maintain a stable temperature, and the pill should remain out of direct sunlight.

Will Avodart affect my ability to drive or operate machinery?

Dutasteride itself does not impair cognition or motor skills. However, some men experience dizziness or fatigue when first starting therapy; they should assess their own response before engaging in activities that require full alertness.

Molecular Structure and Therapeutic Purpose

Dutasteride is a synthetic 4-azasteroid compound primarily utilized to address concerns related to prostate enlargement. By inhibiting specific enzymes, this active substance helps reduce the volume of the prostate gland in men experiencing lower urinary tract symptoms associated with benign prostatic hyperplasia. It functions as a dual inhibitor, which differentiates it from medications that only target one pathway of hormonal regulation.

This compound is utilized in various branded products, most notably Avodart, which is commonly dispensed in Hong Kong healthcare settings. The substance focuses on modulating androgen metabolism, specifically targeting the conversion of testosterone into its more potent form, dihydrotestosterone. Over time, this pharmacological intervention assists in alleviating physical obstruction within the urinary tract.

Pharmaceutical Formulations and Availability

In Hong Kong, Dutasteride is prepared as a soft gelatin capsule for oral intake. These capsules are designed for systemic absorption, allowing the active component to circulate and exert its effects on targeted glandular tissues. Patients may encounter this ingredient under its proprietary brand name or as a generic equivalent, both of which contain the same active chemical structure.

When a healthcare provider suggests this substance, patients will often find it available in a single standard strength. Generic options are subject to the same quality assessments as the original brand to ensure consistency in delivery. The choice between these options often involves local inventory availability and standard practice within the specific pharmacy or clinic consulted.

Targeted Physiological Applications

This API is primarily indicated for the management of benign prostatic hyperplasia (BPH) to reduce the risk of urinary retention and the necessity for surgical intervention. It is also applied in scenarios where patients experience significant difficulty with urine flow or frequent nocturnal urination caused by an enlarged prostate.

Beyond symptomatic relief, the substance is used for long-term stabilization of prostate size. It is generally intended for use in adult males who demonstrate clear clinical signs of prostate-related urinary obstruction. Its role is focused on the mechanical and physiological aspects of gland reduction rather than addressing acute infections or unrelated bladder conditions.

Mechanism of Biological Action

Dutasteride works by deactivating the enzyme responsible for converting testosterone into dihydrotestosterone (DHT) within the body. DHT is a key hormone that promotes the growth of the prostate gland; by limiting its production, the substance encourages a gradual reduction in the size of the gland. This reduction of prostate tissue helps ease the pressure placed upon the urethra.

Because the urethra passes through the center of the prostate, reducing tissue volume allows for more comfortable and efficient urine flow. This pharmacological process does not happen instantly, as it requires consistent, long-term exposure for meaningful anatomical changes to occur in the glandular tissue.

Safety and Monitoring Profiles

Common Reactions

Sensitivity or mild changes in sexual function are occasionally observed. Some individuals may report variations in libido or minor breast tenderness during the initial stages of therapy.

Serious Reactions

Immediate medical assessment is required if an individual experiences unexplained skin rashes, swelling of the face or lips, or severe difficulty breathing, which may signify an allergic reaction. Any signs of persistent changes in breast tissue, such as lumps or discharge, should be reported to a clinician without delay.

Contraindications

This substance is strictly for use by adult males and must never be handled or ingested by women who are pregnant or may become pregnant, as it can cause developmental disturbances to a male fetus. Individuals with severe liver impairment should also exercise extreme caution, as the substance is primarily processed through hepatic pathways.

Interaction Awareness

Alcohol should be used sparingly during treatment, as it may exacerbate urinary symptoms. This ingredient may interact with medications for blood pressure or other hormonal treatments. Please refer to your specific medication’s package insert for a complete, updated list of potential drug interactions specific to your treatment regimen.

Administration and Storage Context

Treatment with this substance is typically intended for chronic, long-term use rather than immediate relief. It is stored at controlled room temperature, kept away from direct light and moisture to maintain its chemical integrity. Because of its specific absorption characteristics, capsules should be swallowed whole. For detailed usage, dosing, and administration, refer to the specific medication's clinical information.

Glossary of Pharmacological Terms

Benign Prostatic Hyperplasia
A condition characterized by the non-cancerous enlargement of the prostate gland which can constrict the urinary passage.
Dihydrotestosterone
A potent androgen hormone that is primarily responsible for the development and maintenance of prostate tissue mass.
Dual Inhibitor
A chemical agent that effectively blocks two different pathways of the same enzyme system to maximize therapeutic impact.

Clinical Disclaimer and Governance

This educational overview provides general information regarding Dutasteride and does not constitute medical instructions or diagnostic advice. Individual medications, such as Avodart, vary significantly in their formulation, specific strength, and precise administration requirements. We disclaim all liability regarding the clinical application or outcomes of using this active ingredient. Patients must consult their specific medication labeling for safe use instructions and seek guidance from a licensed healthcare professional in Hong Kong regarding their unique medical needs.

Categories